While on medication known as GLP-1 (glucagon-like peptide-1), which imitates a hormone naturally produced in the gut that regulates blood sugar, slows digestion and signals fullness in the brain, Bonnie had to temporarily stop the medication after a year and a half when her blood work returned to normal
(PubMed) Savitha S, Panneerselvam C
Combined with semaglutide (CagriSema), it achieved 15.6% weight loss in a phase 2 trial (2022) over 20 weeks, with phase 3 trials underway
They share a manufacturer: Both are made by Eli Lilly
Costs and Affordability of GLP-1 Prescriptions with PlexusDx Once you have a valid prescription, PlexusDx makes medication costs predictable and affordable
Here are the results: Dose-dependent weight loss The phase 2 trial demonstrated a dose-dependent relationship between retatrutide and weight loss